about
Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer. Genmab's proprietary antibody technologies are DuoBody, HexaBody, DuoHexaBody, and HexElect. Johnson & Johnson partnered with Genmab...
Read More
37.00
-0.82
(-2.17%)
2.7M
XNAS Volume
XNAS 16 Oct, 2026 5:30 PM (EDT)
Low Financial Strength
Mid Valuation
Technically Moderately Bullish
Momentum Trap
These stocks have average financials but are currently seeing momentum. Investors should exercise caution in buying these stocks
View Similar
Embed DVM
Genmab (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..